img

Global Generic Drug Research and Development Services Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Generic Drug Research and Development Services Market Research Report 2024

Generic Drug Research and Development Services refers to a service that supports pharmaceutical companies in the process of developing generic drugs. It involves a range of activities and expertise aimed at obtaining regulatory approval for a generic version of a brand-name drug. The service typically includes activities such as formulation development, preclinical studies, bioequivalence testing, clinical trial design and execution, regulatory strategy development, and submission preparation. The service provider may also offer project management and regulatory affairs support throughout the development process. The goal of Generic Drug Development Service is to assist pharmaceutical companies in developing generic drugs that are equivalent to the reference product in terms of dosage form, strength, route of administration, quality, safety, and efficacy. This involves demonstrating bioequivalence through rigorous testing and analysis. By utilizing a Generic Drug Development Service, pharmaceutical companies can streamline the drug development process, reduce costs, and ensure compliance with regulatory requirements. These services can be particularly beneficial for smaller pharmaceutical companies or those with limited in-house capabilities in drug development and regulatory affairs.
According to MRAResearch’s new survey, global Generic Drug Research and Development Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Generic Drug Research and Development Services market research.
Key companies engaged in the Generic Drug Research and Development Services industry include PDG, Navitas Life Sciences, Teva, Avivia, Aavis Pharmaceuticals, CRS, Eurofins, Veeda CRO and JOINN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Generic Drug Research and Development Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Generic Drug Research and Development Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Generic Drug Research and Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


PDG
Navitas Life Sciences
Teva
Avivia
Aavis Pharmaceuticals
CRS
Eurofins
Veeda CRO
JOINN
Tigermed
PHARMARON
DiQi Pharmaceuticals Co, Ltd.
AUSUN PHARM
Beijing Honghui Meditech Co., Ltd.
HiCrystal
MEDICILON
Duo Rul Pharmaceutlcal Co..Ltd
TI Group
TIANHENG
BIOGINGLAM
XINYAO
HIPHAR MEDICAL
NKD PHARM CO, LTD
WuXi AppTec
Segment by Type
On-line Services
Off-line Services

Segment by Application


Government & Regulatory Agencies
Pharmaceutical Company
Academic Centre
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Generic Drug Research and Development Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drug Research and Development Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 On-line Services
1.2.3 Off-line Services
1.3 Market by Application
1.3.1 Global Generic Drug Research and Development Services Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Government & Regulatory Agencies
1.3.3 Pharmaceutical Company
1.3.4 Academic Centre
1.3.5 CRO
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drug Research and Development Services Market Perspective (2018-2033)
2.2 Generic Drug Research and Development Services Growth Trends by Region
2.2.1 Global Generic Drug Research and Development Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Generic Drug Research and Development Services Historic Market Size by Region (2018-2023)
2.2.3 Generic Drug Research and Development Services Forecasted Market Size by Region (2024-2033)
2.3 Generic Drug Research and Development Services Market Dynamics
2.3.1 Generic Drug Research and Development Services Industry Trends
2.3.2 Generic Drug Research and Development Services Market Drivers
2.3.3 Generic Drug Research and Development Services Market Challenges
2.3.4 Generic Drug Research and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drug Research and Development Services Players by Revenue
3.1.1 Global Top Generic Drug Research and Development Services Players by Revenue (2018-2023)
3.1.2 Global Generic Drug Research and Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Generic Drug Research and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Drug Research and Development Services Revenue
3.4 Global Generic Drug Research and Development Services Market Concentration Ratio
3.4.1 Global Generic Drug Research and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drug Research and Development Services Revenue in 2022
3.5 Generic Drug Research and Development Services Key Players Head office and Area Served
3.6 Key Players Generic Drug Research and Development Services Product Solution and Service
3.7 Date of Enter into Generic Drug Research and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drug Research and Development Services Breakdown Data by Type
4.1 Global Generic Drug Research and Development Services Historic Market Size by Type (2018-2023)
4.2 Global Generic Drug Research and Development Services Forecasted Market Size by Type (2024-2033)
5 Generic Drug Research and Development Services Breakdown Data by Application
5.1 Global Generic Drug Research and Development Services Historic Market Size by Application (2018-2023)
5.2 Global Generic Drug Research and Development Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Generic Drug Research and Development Services Market Size (2018-2033)
6.2 North America Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Generic Drug Research and Development Services Market Size by Country (2018-2023)
6.4 North America Generic Drug Research and Development Services Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drug Research and Development Services Market Size (2018-2033)
7.2 Europe Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Generic Drug Research and Development Services Market Size by Country (2018-2023)
7.4 Europe Generic Drug Research and Development Services Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drug Research and Development Services Market Size (2018-2033)
8.2 Asia-Pacific Generic Drug Research and Development Services Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Generic Drug Research and Development Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Generic Drug Research and Development Services Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drug Research and Development Services Market Size (2018-2033)
9.2 Latin America Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Generic Drug Research and Development Services Market Size by Country (2018-2023)
9.4 Latin America Generic Drug Research and Development Services Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drug Research and Development Services Market Size (2018-2033)
10.2 Middle East & Africa Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Generic Drug Research and Development Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Generic Drug Research and Development Services Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PDG
11.1.1 PDG Company Detail
11.1.2 PDG Business Overview
11.1.3 PDG Generic Drug Research and Development Services Introduction
11.1.4 PDG Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.1.5 PDG Recent Development
11.2 Navitas Life Sciences
11.2.1 Navitas Life Sciences Company Detail
11.2.2 Navitas Life Sciences Business Overview
11.2.3 Navitas Life Sciences Generic Drug Research and Development Services Introduction
11.2.4 Navitas Life Sciences Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.2.5 Navitas Life Sciences Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Generic Drug Research and Development Services Introduction
11.3.4 Teva Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.3.5 Teva Recent Development
11.4 Avivia
11.4.1 Avivia Company Detail
11.4.2 Avivia Business Overview
11.4.3 Avivia Generic Drug Research and Development Services Introduction
11.4.4 Avivia Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.4.5 Avivia Recent Development
11.5 Aavis Pharmaceuticals
11.5.1 Aavis Pharmaceuticals Company Detail
11.5.2 Aavis Pharmaceuticals Business Overview
11.5.3 Aavis Pharmaceuticals Generic Drug Research and Development Services Introduction
11.5.4 Aavis Pharmaceuticals Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.5.5 Aavis Pharmaceuticals Recent Development
11.6 CRS
11.6.1 CRS Company Detail
11.6.2 CRS Business Overview
11.6.3 CRS Generic Drug Research and Development Services Introduction
11.6.4 CRS Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.6.5 CRS Recent Development
11.7 Eurofins
11.7.1 Eurofins Company Detail
11.7.2 Eurofins Business Overview
11.7.3 Eurofins Generic Drug Research and Development Services Introduction
11.7.4 Eurofins Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.7.5 Eurofins Recent Development
11.8 Veeda CRO
11.8.1 Veeda CRO Company Detail
11.8.2 Veeda CRO Business Overview
11.8.3 Veeda CRO Generic Drug Research and Development Services Introduction
11.8.4 Veeda CRO Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.8.5 Veeda CRO Recent Development
11.9 JOINN
11.9.1 JOINN Company Detail
11.9.2 JOINN Business Overview
11.9.3 JOINN Generic Drug Research and Development Services Introduction
11.9.4 JOINN Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.9.5 JOINN Recent Development
11.10 Tigermed
11.10.1 Tigermed Company Detail
11.10.2 Tigermed Business Overview
11.10.3 Tigermed Generic Drug Research and Development Services Introduction
11.10.4 Tigermed Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.10.5 Tigermed Recent Development
11.11 PHARMARON
11.11.1 PHARMARON Company Detail
11.11.2 PHARMARON Business Overview
11.11.3 PHARMARON Generic Drug Research and Development Services Introduction
11.11.4 PHARMARON Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.11.5 PHARMARON Recent Development
11.12 DiQi Pharmaceuticals Co, Ltd.
11.12.1 DiQi Pharmaceuticals Co, Ltd. Company Detail
11.12.2 DiQi Pharmaceuticals Co, Ltd. Business Overview
11.12.3 DiQi Pharmaceuticals Co, Ltd. Generic Drug Research and Development Services Introduction
11.12.4 DiQi Pharmaceuticals Co, Ltd. Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.12.5 DiQi Pharmaceuticals Co, Ltd. Recent Development
11.13 AUSUN PHARM
11.13.1 AUSUN PHARM Company Detail
11.13.2 AUSUN PHARM Business Overview
11.13.3 AUSUN PHARM Generic Drug Research and Development Services Introduction
11.13.4 AUSUN PHARM Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.13.5 AUSUN PHARM Recent Development
11.14 Beijing Honghui Meditech Co., Ltd.
11.14.1 Beijing Honghui Meditech Co., Ltd. Company Detail
11.14.2 Beijing Honghui Meditech Co., Ltd. Business Overview
11.14.3 Beijing Honghui Meditech Co., Ltd. Generic Drug Research and Development Services Introduction
11.14.4 Beijing Honghui Meditech Co., Ltd. Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.14.5 Beijing Honghui Meditech Co., Ltd. Recent Development
11.15 HiCrystal
11.15.1 HiCrystal Company Detail
11.15.2 HiCrystal Business Overview
11.15.3 HiCrystal Generic Drug Research and Development Services Introduction
11.15.4 HiCrystal Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.15.5 HiCrystal Recent Development
11.16 MEDICILON
11.16.1 MEDICILON Company Detail
11.16.2 MEDICILON Business Overview
11.16.3 MEDICILON Generic Drug Research and Development Services Introduction
11.16.4 MEDICILON Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.16.5 MEDICILON Recent Development
11.17 Duo Rul Pharmaceutlcal Co..Ltd
11.17.1 Duo Rul Pharmaceutlcal Co..Ltd Company Detail
11.17.2 Duo Rul Pharmaceutlcal Co..Ltd Business Overview
11.17.3 Duo Rul Pharmaceutlcal Co..Ltd Generic Drug Research and Development Services Introduction
11.17.4 Duo Rul Pharmaceutlcal Co..Ltd Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.17.5 Duo Rul Pharmaceutlcal Co..Ltd Recent Development
11.18 TI Group
11.18.1 TI Group Company Detail
11.18.2 TI Group Business Overview
11.18.3 TI Group Generic Drug Research and Development Services Introduction
11.18.4 TI Group Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.18.5 TI Group Recent Development
11.19 TIANHENG
11.19.1 TIANHENG Company Detail
11.19.2 TIANHENG Business Overview
11.19.3 TIANHENG Generic Drug Research and Development Services Introduction
11.19.4 TIANHENG Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.19.5 TIANHENG Recent Development
11.20 BIOGINGLAM
11.20.1 BIOGINGLAM Company Detail
11.20.2 BIOGINGLAM Business Overview
11.20.3 BIOGINGLAM Generic Drug Research and Development Services Introduction
11.20.4 BIOGINGLAM Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.20.5 BIOGINGLAM Recent Development
11.21 XINYAO
11.21.1 XINYAO Company Detail
11.21.2 XINYAO Business Overview
11.21.3 XINYAO Generic Drug Research and Development Services Introduction
11.21.4 XINYAO Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.21.5 XINYAO Recent Development
11.22 HIPHAR MEDICAL
11.22.1 HIPHAR MEDICAL Company Detail
11.22.2 HIPHAR MEDICAL Business Overview
11.22.3 HIPHAR MEDICAL Generic Drug Research and Development Services Introduction
11.22.4 HIPHAR MEDICAL Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.22.5 HIPHAR MEDICAL Recent Development
11.23 NKD PHARM CO, LTD
11.23.1 NKD PHARM CO, LTD Company Detail
11.23.2 NKD PHARM CO, LTD Business Overview
11.23.3 NKD PHARM CO, LTD Generic Drug Research and Development Services Introduction
11.23.4 NKD PHARM CO, LTD Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.23.5 NKD PHARM CO, LTD Recent Development
11.24 WuXi AppTec
11.24.1 WuXi AppTec Company Detail
11.24.2 WuXi AppTec Business Overview
11.24.3 WuXi AppTec Generic Drug Research and Development Services Introduction
11.24.4 WuXi AppTec Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.24.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Generic Drug Research and Development Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of On-line Services
Table 3. Key Players of Off-line Services
Table 4. Global Generic Drug Research and Development Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Generic Drug Research and Development Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Generic Drug Research and Development Services Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Generic Drug Research and Development Services Market Share by Region (2018-2023)
Table 8. Global Generic Drug Research and Development Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Generic Drug Research and Development Services Market Share by Region (2024-2033)
Table 10. Generic Drug Research and Development Services Market Trends
Table 11. Generic Drug Research and Development Services Market Drivers
Table 12. Generic Drug Research and Development Services Market Challenges
Table 13. Generic Drug Research and Development Services Market Restraints
Table 14. Global Generic Drug Research and Development Services Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Generic Drug Research and Development Services Market Share by Players (2018-2023)
Table 16. Global Top Generic Drug Research and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug Research and Development Services as of 2022)
Table 17. Ranking of Global Top Generic Drug Research and Development Services Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Generic Drug Research and Development Services Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Generic Drug Research and Development Services Product Solution and Service
Table 21. Date of Enter into Generic Drug Research and Development Services Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Drug Research and Development Services Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Generic Drug Research and Development Services Revenue Market Share by Type (2018-2023)
Table 25. Global Generic Drug Research and Development Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Generic Drug Research and Development Services Revenue Market Share by Type (2024-2033)
Table 27. Global Generic Drug Research and Development Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Generic Drug Research and Development Services Revenue Market Share by Application (2018-2023)
Table 29. Global Generic Drug Research and Development Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Generic Drug Research and Development Services Revenue Market Share by Application (2024-2033)
Table 31. North America Generic Drug Research and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Generic Drug Research and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Generic Drug Research and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Generic Drug Research and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Generic Drug Research and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Generic Drug Research and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Generic Drug Research and Development Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Generic Drug Research and Development Services Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Generic Drug Research and Development Services Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Generic Drug Research and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Generic Drug Research and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Generic Drug Research and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Generic Drug Research and Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Generic Drug Research and Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Generic Drug Research and Development Services Market Size by Country (2024-2033) & (US$ Million)
Table 46. PDG Company Detail
Table 47. PDG Business Overview
Table 48. PDG Generic Drug Research and Development Services Product
Table 49. PDG Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 50. PDG Recent Development
Table 51. Navitas Life Sciences Company Detail
Table 52. Navitas Life Sciences Business Overview
Table 53. Navitas Life Sciences Generic Drug Research and Development Services Product
Table 54. Navitas Life Sciences Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 55. Navitas Life Sciences Recent Development
Table 56. Teva Company Detail
Table 57. Teva Business Overview
Table 58. Teva Generic Drug Research and Development Services Product
Table 59. Teva Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 60. Teva Recent Development
Table 61. Avivia Company Detail
Table 62. Avivia Business Overview
Table 63. Avivia Generic Drug Research and Development Services Product
Table 64. Avivia Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 65. Avivia Recent Development
Table 66. Aavis Pharmaceuticals Company Detail
Table 67. Aavis Pharmaceuticals Business Overview
Table 68. Aavis Pharmaceuticals Generic Drug Research and Development Services Product
Table 69. Aavis Pharmaceuticals Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 70. Aavis Pharmaceuticals Recent Development
Table 71. CRS Company Detail
Table 72. CRS Business Overview
Table 73. CRS Generic Drug Research and Development Services Product
Table 74. CRS Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 75. CRS Recent Development
Table 76. Eurofins Company Detail
Table 77. Eurofins Business Overview
Table 78. Eurofins Generic Drug Research and Development Services Product
Table 79. Eurofins Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 80. Eurofins Recent Development
Table 81. Veeda CRO Company Detail
Table 82. Veeda CRO Business Overview
Table 83. Veeda CRO Generic Drug Research and Development Services Product
Table 84. Veeda CRO Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 85. Veeda CRO Recent Development
Table 86. JOINN Company Detail
Table 87. JOINN Business Overview
Table 88. JOINN Generic Drug Research and Development Services Product
Table 89. JOINN Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 90. JOINN Recent Development
Table 91. Tigermed Company Detail
Table 92. Tigermed Business Overview
Table 93. Tigermed Generic Drug Research and Development Services Product
Table 94. Tigermed Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 95. Tigermed Recent Development
Table 96. PHARMARON Company Detail
Table 97. PHARMARON Business Overview
Table 98. PHARMARON Generic Drug Research and Development Services Product
Table 99. PHARMARON Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 100. PHARMARON Recent Development
Table 101. DiQi Pharmaceuticals Co, Ltd. Company Detail
Table 102. DiQi Pharmaceuticals Co, Ltd. Business Overview
Table 103. DiQi Pharmaceuticals Co, Ltd. Generic Drug Research and Development Services Product
Table 104. DiQi Pharmaceuticals Co, Ltd. Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 105. DiQi Pharmaceuticals Co, Ltd. Recent Development
Table 106. AUSUN PHARM Company Detail
Table 107. AUSUN PHARM Business Overview
Table 108. AUSUN PHARM Generic Drug Research and Development Services Product
Table 109. AUSUN PHARM Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 110. AUSUN PHARM Recent Development
Table 111. Beijing Honghui Meditech Co., Ltd. Company Detail
Table 112. Beijing Honghui Meditech Co., Ltd. Business Overview
Table 113. Beijing Honghui Meditech Co., Ltd. Generic Drug Research and Development Services Product
Table 114. Beijing Honghui Meditech Co., Ltd. Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 115. Beijing Honghui Meditech Co., Ltd. Recent Development
Table 116. HiCrystal Company Detail
Table 117. HiCrystal Business Overview
Table 118. HiCrystal Generic Drug Research and Development Services Product
Table 119. HiCrystal Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 120. HiCrystal Recent Development
Table 121. MEDICILON Company Detail
Table 122. MEDICILON Business Overview
Table 123. MEDICILON Generic Drug Research and Development Services Product
Table 124. MEDICILON Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 125. MEDICILON Recent Development
Table 126. Duo Rul Pharmaceutlcal Co..Ltd Company Detail
Table 127. Duo Rul Pharmaceutlcal Co..Ltd Business Overview
Table 128. Duo Rul Pharmaceutlcal Co..Ltd Generic Drug Research and Development Services Product
Table 129. Duo Rul Pharmaceutlcal Co..Ltd Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 130. Duo Rul Pharmaceutlcal Co..Ltd Recent Development
Table 131. TI Group Company Detail
Table 132. TI Group Business Overview
Table 133. TI Group Generic Drug Research and Development Services Product
Table 134. TI Group Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 135. TI Group Recent Development
Table 136. TIANHENG Company Detail
Table 137. TIANHENG Business Overview
Table 138. TIANHENG Generic Drug Research and Development Services Product
Table 139. TIANHENG Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 140. TIANHENG Recent Development
Table 141. BIOGINGLAM Company Detail
Table 142. BIOGINGLAM Business Overview
Table 143. BIOGINGLAM Generic Drug Research and Development Services Product
Table 144. BIOGINGLAM Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 145. BIOGINGLAM Recent Development
Table 146. XINYAO Company Detail
Table 147. XINYAO Business Overview
Table 148. XINYAO Generic Drug Research and Development Services Product
Table 149. XINYAO Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 150. XINYAO Recent Development
Table 151. HIPHAR MEDICAL Company Detail
Table 152. HIPHAR MEDICAL Business Overview
Table 153. HIPHAR MEDICAL Generic Drug Research and Development Services Product
Table 154. HIPHAR MEDICAL Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 155. HIPHAR MEDICAL Recent Development
Table 156. NKD PHARM CO, LTD Company Detail
Table 157. NKD PHARM CO, LTD Business Overview
Table 158. NKD PHARM CO, LTD Generic Drug Research and Development Services Product
Table 159. NKD PHARM CO, LTD Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 160. NKD PHARM CO, LTD Recent Development
Table 161. WuXi AppTec Company Detail
Table 162. WuXi AppTec Business Overview
Table 163. WuXi AppTec Generic Drug Research and Development Services Product
Table 164. WuXi AppTec Revenue in Generic Drug Research and Development Services Business (2018-2023) & (US$ Million)
Table 165. WuXi AppTec Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Drug Research and Development Services Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Generic Drug Research and Development Services Market Share by Type: 2022 VS 2033
Figure 3. On-line Services Features
Figure 4. Off-line Services Features
Figure 5. Global Generic Drug Research and Development Services Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Generic Drug Research and Development Services Market Share by Application: 2022 VS 2033
Figure 7. Government & Regulatory Agencies Case Studies
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Academic Centre Case Studies
Figure 10. CRO Case Studies
Figure 11. Others Case Studies
Figure 12. Generic Drug Research and Development Services Report Years Considered
Figure 13. Global Generic Drug Research and Development Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Generic Drug Research and Development Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Generic Drug Research and Development Services Market Share by Region: 2022 VS 2033
Figure 16. Global Generic Drug Research and Development Services Market Share by Players in 2022
Figure 17. Global Top Generic Drug Research and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug Research and Development Services as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Generic Drug Research and Development Services Revenue in 2022
Figure 19. North America Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Generic Drug Research and Development Services Market Share by Country (2018-2033)
Figure 21. United States Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Generic Drug Research and Development Services Market Share by Country (2018-2033)
Figure 25. Germany Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Generic Drug Research and Development Services Market Share by Region (2018-2033)
Figure 33. China Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Generic Drug Research and Development Services Market Share by Country (2018-2033)
Figure 41. Mexico Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Generic Drug Research and Development Services Market Share by Country (2018-2033)
Figure 45. Turkey Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Generic Drug Research and Development Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. PDG Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 48. Navitas Life Sciences Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 49. Teva Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 50. Avivia Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 51. Aavis Pharmaceuticals Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 52. CRS Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 53. Eurofins Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 54. Veeda CRO Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 55. JOINN Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 56. Tigermed Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 57. PHARMARON Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 58. DiQi Pharmaceuticals Co, Ltd. Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 59. AUSUN PHARM Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 60. Beijing Honghui Meditech Co., Ltd. Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 61. HiCrystal Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 62. MEDICILON Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 63. Duo Rul Pharmaceutlcal Co..Ltd Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 64. TI Group Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 65. TIANHENG Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 66. BIOGINGLAM Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 67. XINYAO Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 68. HIPHAR MEDICAL Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 69. NKD PHARM CO, LTD Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 70. WuXi AppTec Revenue Growth Rate in Generic Drug Research and Development Services Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries